Harel Insurance Investments & Financial Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $48.7M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $46.3M | Hold |
|
|||||
|
2023
Q2 | $52.7M | Sell |
|
|||||
|
2023
Q1 | $48.3M | Sell |
|
|||||
|
2022
Q4 | $99.3M | Sell |
|
|||||
|
2022
Q3 | $95.2M | Hold |
|
|||||
|
2022
Q2 | $89.1M | Buy |
|
|||||
|
2022
Q1 | $4.58M | Buy |
|
|||||
|
2021
Q4 | $5.17M | Hold |
|
|||||
|
2021
Q3 | $5.8M | Buy |
|
|||||
|
2021
Q2 | $24K | Hold |
|
|||||
|
2021
Q1 | $24K | Hold |
|
|||||
|
2020
Q4 | $15K | Sell |
|
|||||
|
2020
Q3 | $465K | Hold |
|
|||||
|
2020
Q2 | $467K | Sell |
|
|||||
|
2020
Q1 | $556K | Buy |
|
|||||
|
2019
Q4 | $292K | Sell |
|
|||||
|
2019
Q3 | $280K | Buy |
|
|||||
|
2019
Q2 | $235K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $15.7M | Buy |
|
|||||
|
2018
Q3 | $20.1M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $206K | Buy |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $468K | Buy |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $867K | Buy |
|